| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 230.70B | 252.97B | 182.84B | 137.23B | 119.29B | 105.72B |
| Gross Profit | 184.00B | 193.79B | 151.72B | 123.64B | 111.23B | 100.49B |
| EBITDA | 97.13B | 110.99B | 71.52B | 53.40B | 43.28B | 27.91B |
| Net Income | 68.72B | 73.07B | 50.78B | 34.44B | 27.69B | 20.04B |
Balance Sheet | ||||||
| Total Assets | 16.89T | 16.59T | 14.75T | 13.48T | 11.59T | 9.49T |
| Cash, Cash Equivalents and Short-Term Investments | 4.92T | 4.14T | 4.24T | 4.79T | 4.05T | 3.65T |
| Total Debt | 2.90T | 2.82T | 2.76T | 2.58T | 2.31T | 2.25T |
| Total Liabilities | 16.52T | 16.20T | 14.43T | 13.20T | 11.36T | 9.28T |
| Stockholders Equity | 354.05B | 372.07B | 302.25B | 260.69B | 213.03B | 187.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 52.56B | 62.83B | -404.89B | -418.31B | -145.27B |
| Operating Cash Flow | 0.00 | 54.05B | 63.41B | -403.58B | -416.89B | -144.50B |
| Investing Cash Flow | 0.00 | -1.80T | -1.83T | -611.99B | -1.25T | -1.87T |
| Financing Cash Flow | 0.00 | 1.64T | 1.22T | 1.76T | 2.07T | 2.98T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥2.03T | 5.92 | 20.02% | 2.63% | 31.37% | 148.24% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | ¥715.79B | 9.05 | 7.97% | 3.48% | 6.29% | 147.90% | |
61 Neutral | ¥341.77B | 14.33 | 3.46% | 3.04% | 7.13% | 34.82% | |
58 Neutral | ¥261.85B | 21.84 | ― | 3.66% | 2.57% | -20.63% | |
57 Neutral | ¥1.15T | 13.47 | ― | ― | 38.64% | 43.89% | |
56 Neutral | ¥164.57B | 15.43 | 7.26% | 4.16% | 46.50% | ― |